XML 50 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Basis of Presentation and Liquidity (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
May 26, 2020
Apr. 24, 2020
Feb. 04, 2020
May 22, 2019
Sep. 05, 2018
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Reverse split of common stock       1-for-9 reverse stock split            
Reverse stock split       $ 5.58            
Noncontrolling interest, description               Outside shareholders' interest in SRP of 37.5% is shown on the condensed consolidated balance sheet as noncontrolling interest.    
Accumulated deficit           $ (130,087)   $ (130,087)   $ (127,332)
Proceeds from common stock               6,771 $ 1,992  
PPP funds received amount   $ 500                
Allowance for doubtful accounts receivable               25
Provision for bad debt expense            
Write-offs of accounts receivable           25 1 25 5  
Sales returns and allowances                
Depreciation expense           6 8 11 16  
Cost of Goods Sold [Member]                    
Depreciation expense           4 $ 4 $ 8 $ 6  
Loan Agreement [Member]                    
Revolving credit outstanding amount                  
Loan Agreement [Member] | Lender [Member]                    
Revolving credit capacity                  
Underwritten Public Offering [Member]                    
Number of shares sold in common stock, shares     937,500              
Private Placement [Member] | Specialty Renal Products, Inc. [Member]                    
Proceeds from common stock         $ 3,000          
Private Placement [Member] | Specialty Renal Products, Inc. [Member] | Minority Interest Ownership [Member]                    
Equity method investment, ownership percentage         37.50%